Dr. Guy Chamberland is the CEO of Tetra Bio-Pharma, a leader in drug discovery and development for cannabinoid-based therapeutics. The company has been a partner of Business of Cannabis for our Medical Cannabis Week – specifically about the good work being done in Atlantic Canada. Chamberland joined BofCLive to talk about recently announced agreement with Thorne Research and Onegevity Health to form a new joint venture: CB2 Therapeutics.
